InvestSMART

Algorae Pharmaceuticals Limited (ASX: 1AI) - Announcements

Current share price for 1AI : $0.009 0 (5.56%)+

ASX company news and announcements for Algorae Pharmaceuticals Limited (1AI) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Algorae Pharmaceuticals Limited (1AI) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Algorae Pharmaceuticals Limited (1AI), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Algorae Pharmaceuticals Limited (1AI)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$17 Notice of Annual General Meeting/Proxy Form 7 Oct 2026 4:46PM $0.009 $0.009 fallen by 5.56%
$17 Change of Director's Interest Notice - DH 30 Sep 2026 5:03PM $0.009 $0.009 fallen by 5.56%
$17 Date of AGM and Closing Date for Director Nominations 10 Sep 2026 8:22AM $0.010 $0.009 fallen by 15%
$17 Notification of cessation of securities - 1AI 2 Sep 2026 5:19PM $0.011 $0.009 fallen by 22.73%
$17 Appendix 4G and Corporate Governance Statement 31 Aug 2026 4:06PM $0.010 $0.009 fallen by 15%
$17 Appendix 4E and 2026 Annual Report 31 Aug 2026 4:02PM $0.010 $0.009 fallen by 15%
$17 Quarterly Activities Report/Appendix 4C Cashflow Statement 31 Jul 2026 9:14AM $0.012 $0.009 fallen by 29.17%
$17 Initial Director's Interest Notice - TV 21 Jul 2026 5:19PM $0.012 $0.009 fallen by 29.17%
$17 Final Director's Interest Notice - BD 21 Jul 2026 5:16PM $0.012 $0.009 fallen by 29.17%
$17 Notification of cessation of securities - 1AI 21 Jul 2026 5:14PM $0.012 $0.009 fallen by 29.17%
$17 Nasdaq Pharma Chairman Troy Valentine Joins Algorae Board 15 Jul 2026 8:59AM $0.013 $0.009 fallen by 32%
$17 Cleansing Notice 6 Jul 2026 4:29PM $0.013 $0.009 fallen by 34.62%
$17 Application for quotation of securities - 1AI 6 Jul 2026 4:26PM $0.013 $0.009 fallen by 34.62%
$17 Peter Mac Testing Validates AlgoraeOS v2 3 Jul 2026 9:03AM $0.012 $0.009 fallen by 29.17%
$17 Updated - NSW Health Public Hospital Supply Contract 2 Jul 2026 9:47AM $0.013 $0.009 fallen by 34.62%
$17 Algorae Awarded NSW Health Public Hospital Supply Contract 1 Jul 2026 9:03AM $0.010 $0.009 fallen by 15%
$17 Company Secretary Appointment/Resignation 30 Jun 2026 4:19PM $0.010 $0.009 fallen by 15%
$17 Algorae Named Launch Partner for Sovereign AI Initiative 29 Jun 2026 9:02AM $0.011 $0.009 fallen by 22.73%
$17 Change of Auditor 24 Jun 2026 6:27PM $0.010 $0.009 fallen by 15%
$17 Cleansing Notice 19 Jun 2026 5:18PM $0.011 $0.009 fallen by 19.05%
$17 Application for quotation of securities - 1AI 19 Jun 2026 5:15PM $0.011 $0.009 fallen by 19.05%
$17 Application for quotation of securities - 1AI 19 Jun 2026 5:12PM $0.011 $0.009 fallen by 19.05%
$17 Proposed issue of securities - 1AI 16 Jun 2026 6:03PM $0.011 $0.009 fallen by 19.05%
$17 Notification regarding unquoted securities - 1AI 25 May 2026 5:23PM $0.012 $0.009 fallen by 29.17%
$17 Application for quotation of securities - 1AI 25 May 2026 5:19PM $0.012 $0.009 fallen by 29.17%

1 - 25 of 193 results

Page 1 of 8

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.